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In Drosophila embryos and larvae, a small number of
identified motor neurons innervate body wall mus-
cles in a highly stereotyped pattern. Although genetic
screens have identified many proteins that are re-
quired for axon guidance and synaptogenesis in
this system, little is known about the mechanisms
bywhichmuscle fibers are defined as targets for spe-
cific motor axons. To identify potential target labels,
we screened 410 genes encoding cell-surface and
secreted proteins, searching for those whose over-
expression on all muscle fibers causes motor axons
to make targeting errors. Thirty such genes were
identified, and a number of these were members of
a large gene family encoding proteins whose extra-
cellular domains contain leucine-rich repeat (LRR)
sequences, which are protein interaction modules.
By manipulating gene expression in muscle 12, we
showed that four LRR proteins participate in the
selection of this muscle as the appropriate synaptic
target for the RP5 motor neuron.
INTRODUCTION
Genetic screens in Drosophila and C. elegans have identified
cell-surface and secreted (CSS) proteins involved in axon guid-
ance, synaptic target selection, and presynaptic differentiation.
In some cases these steps involve distinct sets of CSS proteins,
while in others overlapping sets of proteins are involved in multi-
ple steps. Mutations affecting immunoglobulin (Ig)-domain cell
adhesion molecules (CAMs), cadherins, receptor tyrosine phos-
phatases, and Wnt proteins can produce phenotypes in which
axons reach their targets but then fail to form normal synapses
(Inaki et al., 2007; Klassen and Shen, 2007; reviewed by Johnson
and Van Vactor, 2003; Shen, 2004).
One of the most accessible systems for examination of target
selection is the Drosophila larval neuromuscular system. This is
a simpler subset of the central nervous system (CNS), with
only 36 identified motor neurons per abdominal hemisegment
(reviewed by Ruiz-Canada and Budnik, 2006). These neurons
972 Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc.innervate a set of 30 body wall muscle fibers in an invariant
pattern.
Motor axons leave the CNS in three nerve roots: the ISN, SN,
and TN. One of the ISN branches, ISNb (also called SNb) initially
follows the ISN pathway, leaving it at the ‘‘exit junction’’ to enter
the ventrolateral muscle (VLM) field. ISNb innervates sevenmus-
cles: 6, 7, 12, and 13 (internal layer), and 14, 30, and 28 (external
layer). The SNa branch bifurcates at the dorsal edge of the VLMs;
its ventral (or posterior) branch innervates muscles 5 and 8,
which are immediately dorsal to the VLMs. The two TN axons
fasciculate with the axon of the peripheral LBD neuron to form
the TN tract. Every axon and synapse in the neuromuscular
system can be visualized in dissected ‘‘fillet’’ preparations of
embryos or larvae stained with antibodies such as monoclonal
antibody (mAb) 1D4 (Vactor et al., 1993).
Neuromuscular junctions (NMJs) increase greatly in size dur-
ing the three stages (instars) of larval life in order to keep pace
with the growth of the muscle fibers. Each NMJ arbor has a
stereotyped pattern of outgrowth. However, NMJ growth is not
autonomously determined within the motor neuron, but is driven
by a homeostatic relationship between the neuron and its post-
synaptic target (reviewed by Davis, 2006). Some of the signaling
mechanisms involved in homeostasis resemble those used for
synaptic development and plasticity in mammalian systems.
Furthermore, the NMJ is a glutamatergic synapse that uses or-
thologs of vertebrate AMPA receptors. These features make
theDrosophila NMJ a useful genetic model system for excitatory
synapses in the mammalian brain.
Many proteins involved in guidance of motor neuron growth
cones have been identified. However, we know relatively little
about how individual fibers within a muscle field are selected
for innervation by specific motor axons. Two models, which
are not mutually exclusive, have been proposed. In the relative
balance model, each fiber is defined as a target by a mixture of
generally expressed attractive and repulsive axon guidance
cues that distinguish it from its neighbors (Winberg et al.,
1998). In the lock-and-key model, individual muscle fibers are
specified by molecular labels that are recognized by receptors
expressed by the innervating neurons (Hoang and Chiba, 1999).
The relative balance model was evaluated by altering expres-
sion of Netrin B (NetB), Semaphorin II (SemaII), and Fasciclin II
(FasII) proteins on the VLMs. Netrins and Semaphorins regulate
axon guidance in multiple contexts, while FasII is a homophilic
Ig-CAM involved in axonal fasciculation. SemaII and FasII are
expressed by all muscles, while NetB is expressed by muscles
6 and 7, which are innervated by the RP3 neuron. Removal of
the attractive NetB cue reduces innervation of the 6/7 cleft by
RP3, as does increasing muscle expression of the repulsive
SemaII cue.
Reducing SemaII levels causes the TN to make ectopic
contacts on the VLMs, and this phenotype is strengthened by in-
creasing FasII expression on muscles. Thus, VLM innervation
can be controlled by adjusting the relative levels of a few attrac-
tive, repulsive, and adhesive cues. However, these cues are not
essential for targeting: in a SemaII NetB double mutant lacking
both attraction and repulsion, or in a FasII mutant, RP3 inner-
vates the 6/7 cleft and the ISNb has a relatively normal morphol-
ogy (Winberg et al., 1998).
Investigations of the lock-and-key model have focused on
CSS proteins that are expressed on individual VLM fibers. Fasci-
clin III (FasIII) is a homophilic Ig-CAM that is expressed on the
RP3 growth cone and at the 6/7 cleft. Its adhesive properties
and expression patternmake it an ideal candidate for an RP3 tar-
get label, but in a FasIII null mutant, RP3 still innervates muscles
6 and 7. When FasIII is expressed on the surrounding muscles in
a wild-type background, however, RP3mistargets to thesemus-
cles. Removing FasIII from the neuron suppresses mistargeting
(Chiba et al., 1995; Kose et al., 1997). These results show that
FasIII-mediated homophilic adhesion can divert RP3 to the
wrong muscles, but is not required for RP30s recognition of its
normal target.
Capricious (Caps) is a leucine-rich repeat (LRR) protein that is
expressed on muscle 12, as well as on ventral muscles and
a subset of dorsal muscles. When Caps is ectopically expressed
on all muscles, a strong larval mistargeting phenotype (‘‘12/13
loopback’’) is observed in which the muscle 12 NMJ sends a
collateral branch back onto muscle 13. caps null mutants have
low-penetrance loopback phenotypes involving only a few
boutons (Shishido et al., 1998).
mRNA encoding the secreted proteinWnt4 is enriched inmus-
cle 13. InWnt4 LOFmutant embryos, RP5 axons, which normally
target to muscle 12, transiently form synapses on muscle 13,
suggesting that Wnt4 is a repulsive cue that normally prevents
RP5 from synapsing on muscle 13 (Inaki et al., 2007).
The data summarized above show that although alterations in
CSS protein expression can influence target selection in the
neuromuscular system, none of the CSS cues that have been
identified thus far are required for normal targeting. This may
be partially due to genetic redundancy. Each muscle fiber might
express several different cues, any of which can be used for tar-
get recognition by innervating growth cones. Consistent with this
interpretation, the only identified gene for which LOF mutations
produce strong targeting phenotypes is abrupt (ab), which
encodes a transcription factor expressed in muscles. In ab
embryos, ISNb nerves have a variety of different abnormal mor-
phologies, suggesting that axons cannot recognize any of the
VLMs as targets. Perhaps Ab regulates a battery of ISNb muscle
targeting cues, and all of these cues are absent or misregulated
in ab mutants (Hu et al., 1995).
The results on FasIII and Caps suggest that new target labels
couldbe identifiedbyperforming again-of-function (GOF) screen
Neuron
LRR Proteins Mediate Synaptic Target Selectionfor genes whose overexpression on all muscles cause axonal
mistargeting phenotypes without affecting the structures of the
muscles themselves. Overexpression/misexpression screens
are commonly done using ‘‘EP’’-like transposable elements,
which contain ‘‘UAS’’ sequences recognized by the yeast tran-
scriptional activator GAL4 upstream of a basal promoter (Rorth
et al., 1998). Like other P elements, EPs tend to transpose into
the 50 endsof genes.When anEP linewith a 50 insertion is crossed
to a ‘‘driver’’ line expressing GAL4 in a particular cell type, the
gene downstream of the EP will be expressed in that cell type
in the F1 progeny of the cross (Brand and Perrimon, 1993). In
one screen of this type, 500 random EP insertions were crossed
to thepanmuscle24B-GAL4driver (Luoet al., 1994) andF1 larvae
examined for mistargeting defects (Umemiya et al., 2002).
In our screen, we planned to examine individual larvae by con-
focal microscopy in order to ensure that we could detect subtle
phenotypes. This meant that we could not analyze thousands of
lines, as would be required in order to identify genes encoding
CSS proteins in a random EP screen. We thus decided to
conduct a ‘‘directed’’ screen of genes encoding CSS proteins
that are likely to be involved in cell recognition events. To do
this, we constructed a database of Drosophila genes that en-
code such proteins, and found EP-like insertions that could drive
410 of these genes. The EP lines were crossed to 24B-GAL4 and
the resulting F1 larvae examined for mistargeting and synaptic
phenotypes.
Our screen cannot assay all CSS proteins encoded in the
genome. However, we hoped that identification of all the mistar-
geting genes within the 40% of the CSS repertoire accessible
through EP lines would inform us as to which protein families are
likely to include target labels. We may have succeeded in this
effort, because our screen identified 16 CSS LRR proteins that
either cause axonal mistargeting or affect NMJ arbor structure
when they are expressed on all muscles. Here we present
evidence that four LRR proteins actually function as synaptic
targeting cues.
RESULTS
A Database of Cell-Surface and Secreted Proteins
To create a database of Drosophila CSS proteins potentially
involved in cell recognition, we performed BLAST searches
with extracellular (XC) domain sequences from a variety of spe-
cies and collated published information (see Supplemental Text
available online for details). The database (Table S1) contains
976 proteins and more than 80 domain types. We then searched
through all existing collections of UAS-containing EP-like lines
and obtained those with insertions 50 to CSS database genes
that could be used to drive their expression. These insertions
should drive 410 of the 976 genes in the database, or over
40% of the cell recognition repertoire (Tables S1 and S2). Fifty-
three of these 410 genes encode proteins with LRRs.
Targeting Events Examined in the Screen
The ISNb contains the axons of seven type I (glutamatergic)
neurons, including RP1, 3, 4, and 5, which are 1b (big boutons)
neurons (Hoang andChiba, 2001; Landgraf et al., 1997). After en-
tering the VLM field, the ISNb axon bundle extends dorsally,Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc. 973
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muscle layers (diagram in Figure 1B). The RP3 axon leaves the
bundle and forms an NMJ in the cleft between muscles 6 and
7. The remaining axons then traverse to the internal face of mus-
cle 13, where RP1 and 4 form synapses. The RP5 axon grows
past muscle 13 to the ISNb termination point on the internal
face of muscle 12. In early stage 17 embryos, the nascent RP5
synapses are at the ventral edge of muscle 12, but by first instar,
RP5 has formed an NMJ that extends across themuscle surface.
By third instar, all of the VLMs are also innervated by a 1s (small
boutons) neuron.
The internal surfaces of muscles 13 and 12 lie in a plane, and
the RP5 growth cone that will innervatemuscle 12 has full access
to bothmuscles when it reaches the embryonic ISNb termination
point. This may account for the observation that the muscle 12
versus 13 decision is often perturbed in ectopic expression
experiments (Shishido et al., 1998; Umemiya et al., 2002).
Execution of the Screen
We screened the CSS insertion collection for genes conferring
ISNb mistargeting and/or presynaptic terminal phenotypes
when overexpressed in postsynaptic cells. To do this, 462 inser-
tion lines representing 410 genes (Table S2) were crossed to the
24B-GAL4 driver, which confers high-level expression in all
Figure 1. Flowchart of the Screen
(A) Outline of the steps in the screen.
(B) Diagram of the pathways taken by ISNb axons
within the VLM field. Left, face-on view of the
VLMs. The LBD (triangle shape) is indicated. Un-
derlying muscles 14 and 30 are shaded. Right,
side view, with the interior of the embryo to the
left. EJ, exit junction. The seven VLM fibers are
shaded.
somatic muscles from stage 12 onward,
persisting into third instar (Luo et al.,
1994). F1 third-instar larvae from these
crosses were stained with mAb 1D4 to vi-
sualize axons and NMJs. Muscles were
visualized with UAS-GFP driven by 24B-
GAL4 or by Alexa-488-phalloidin stain-
ing. For the initial screen of each cross,
we examined the VLM regions of 10 A2
hemisegments (five larvae) using confo-
cal microscopy. Genes producingmistar-
geting were then tested with another
early panmuscle driver (G14-GAL4) and
a panneuronal driver (Elav-GAL4; see
screen flowchart in Figure 1A). The nor-
mal pattern of innervation is shown in
Figure 2A and depicted schematically in
Figure 8. The 30 genes conferring mistar-
geting with R30% penetrance are listed
in Tables 1 and S3, and Figure 2 shows
examples of phenotypes.
We also found 55 other genes whose
overexpression in postsynaptic muscles
caused major alterations in the morphologies of NMJ presynap-
tic terminals without affecting the structures of the muscles
themselves (Figure S1; Table S4). The screen is described in
detail in the Supplemental Text.
Selection of LRR Mistargeting Genes
To identify mistargeting genes that are normally expressed in
cells that would be contacted by ISNb axons during their
outgrowth through the VLM field and therefore might encode
genuine targeting molecules, we examined their expression in
wild-type embryos using in situ hybridization. The cells of interest
include the VLMs themselves, ventral peripheral nervous system
(PNS) neurons, ventral tracheal branches, ventral epidermis, and
peripheral glia. Six ‘‘new’’ genes (those not previously character-
ized using genetics; group 1 in Table 1) were found to be
expressed in some of these cells, as were six previously charac-
terized genes (group 3 in Table 1). We noted that 5 of these
12 genes encode cell-surface LRR proteins: Caps, Tartan (Trn),
18-wheeler (18w), CG14351, and CG3413/Windpipe. All other
domain types (Ig, ZP/PAN, Netrin, ConA, and others) are repre-
sented by only a single gene within this group. Groups 2 (new
genes) and 4 (previously characterized genes) in Table 1 may or
may not be expressed in the cells of interest (see Table S3 for
further information on all mistargeting genes).
974 Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc.
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types
Confocal z-stack images of third-instar F1 larvae
stained with 1D4 (green) and Alexa 488-phalloidin
or anti-GFP (gray).
(A) Control (UAS-GFP, 24B-GAL4 x w). The NMJs
on muscle (m) 6/7, 13, and 12 are evident.
(B) NetB. Top arrowhead, an NMJ from an uniden-
tified neuron grows onto m12 from below (type 3
phenotype; see Figure 4A for phenotypic dia-
grams). Bottom arrowhead, truncated normal
m12 NMJ.
(C) caps.
(D) trn. Arrowheads in (C) and (D), 12/13 loop-
back phenotype (type 1).
(E) CG2901. Arrowhead, the entire NMJ remains at
the 12/13 junction and does not grow onto m12
(type 2).
(F) pot/CG2467. Arrowheads, ectopic NMJs
(probably from m13) innervating m6 (type 7).
(G) 18w. Arrowheads, type 3 (top) and type 7
(bottom) ectopic NMJs.
(H) CG7291/NPC2. Arrowhead, type 3 ectopic
NMJ.
(I) CG5758. Arrowhead, 12/13 loopback pheno-
type (type 1); note the complex multilooped
structure of this NMJ.
Bar in (A), 50mm; applies to all panels.Within the LRR set, we initially focused on Trn, Caps, and
CG14351 because they are normally expressed by muscles
(Artero et al., 2003; Shishido et al., 1998; Figure S2). We also
selected CG8561, an LRR gene identified as producing NMJ
phenotypes (Figure 1A; Table S4), for further investigation.
CG8561 generates mistargeting with 20% penetrance and is
expressed in muscles (Figure S3).
Tartan and Capricious Regulate Motor Axon
Guidance and Targeting in the Embryo
The XC domains of Trn and Caps are 65% identical (Chang et al.,
1993; Shishido et al., 1998). Studies of Trn and Caps function in
imaginal discs suggest that the two proteins can interact with
a common receptor (Milan et al., 2005), and trn caps double
mutants have stronger boundary formation phenotypes during
leg segmentation than do single mutants (Sakurai et al., 2007).
These results suggest that Trn and Caps might also function in
a redundant manner to regulate axon guidance and label
muscles as axonal targets. caps LOF mutants have very weak
mistargeting phenotypes (Shishido et al., 1998), so Caps alone
is not necessary for targeting.
We could not assess trn LOF phenotypes in larvae, because
trn mutants die before third instar. We made trn RNAi lines
from our own inverted repeat constructs, but these did not
produce larval phenotypes when crossed to 24B-GAL4 or other
drivers. Thus, to define the trn phenotype, and to ascertainwhether Trn and Caps have redundant functions, we examined
trn, caps, and trn caps phenotypes in embryos.
We evaluated phenotypes for two trn alleles: trn28.4, which
deletes coding sequence and is likely to be a null allele, and
trns064117, an embryonic lethal insertion mutation that does not
interrupt the coding region. We also examined caps65.2, a null
excision allele, and the double mutant trns064117 caps65.2. We
quantitated motor axon phenotypes in late stage 16/early stage
17 embryo fillets by staining with mAb 1D4 and scoring
segments A2–A7 (Figure 3H).
trn28.4 homozygotes had a mild CNS phenotype and some
muscle patterning defects (see also Artero et al., 2003). We
quantitated phenotypes in hemisegments with normal muscles,
and found that they had strong motor axon guidance pheno-
types that primarily affected the ISNb and SNa nerves (Fig-
ure 3H). These included ‘‘stall’’ phenotypes in which the ISNb
was truncated ventral to muscle 13, suggesting that the axons
stopped prematurely, ‘‘bypass’’ phenotypes in which the ISNb
failed to leave the ISN pathway at the exit junction, and SNa
bifurcation failures (see Figure 1B for normal embryonic ISNb
pathways).
trns064117 mutants had no visible CNS phenotypes and only
rare muscle-patterning defects. They displayed a similar spec-
trum of motor axon guidance phenotypes to trn28.4 embryos,
but with a lower penetrance (25% ISNb, 29% SNa defects for
trns064117, versus 40% ISNb, 33% SNa defects for trn28.4;Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc. 975
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LRR Proteins Mediate Synaptic Target SelectionFigure 3H). caps65.2 embryos had weak ISNb phenotypes and no
SNa phenotypes (15% total ISNb defects and 2% SNa defects
were observed in caps mutants, while the background ISNb
defect penetrance was 7% for TM3armGFP/+ (balancer control)
embryos; the background SNa defect penetrance was 2%).
Ectopic ISNb projections to the TN were described in an earlier
study of caps mutant embryos, but the penetrance was not
reported (Abrell and Jackle, 2001). We occasionally saw such
Table 1. Mistargeting Genes Identified in the Screen
Gene Name/CG Protein Domains
SP, TM
Domains 24B %
Group 1
CG14351/haf LRR-8 SP, TM-1 30%
CG3413/windpipe LRR-2 SP, TM-1 30%
CG2901 SPX, EXS TM-4? 100%
CG9342 Lipoprotein N-terminal SP 30%
CG8668 Glycosyltransferase SP 30%
CG11372/galectin ConA SP 40%
Group 2
CG7291/NPC2 ML SP 30%
CG12004 DUF300 TM-7 30%
CG5758 Fasciclin I SP 50%
CG32373 Sushi/CCP(EGF-like) SP 30%
CG7179 CUB SP 30%
CG7447 EGF-like SP 30%
CG14469/Dpr12 Ig SP 30%
CG2578/ten-a EGF-like TM-1 40%
CG5634/distracted CUB (SP), TM-1 40%
CG10772/fur-1 Furin TM-2 30%
Group 3
tartan LRR-10 SP, TM-1 60%
18-wheeler LRR-20 SP, TM-1 40%
capricious LRR-11 SP, TM-1 60%
NetB Netrin SP 80%
papillote/CG2467 ZP/PAN SP, TM-1 50%
neuromusculin Ig9 TM-1 30%
Group 4
hikaru genki Sushi/CCP(EGF-like) SP 40%
robo2 Ig/FN3 (SP), TM-1 40%
pvf3/CG34378 PDGF SP 30%
shifted WIF SP 30%
turtle Ig/FN3 TM-1 40%
neurexin IV EGF-like SP 30%
Gliotactin Acetylcholinesterase (SP), TM-1 30%
outstretched none SP 30%
Genes in group 1 and group 2 are ‘‘new’’; group 3 and group 4 geneswere
previously characterized using genetics. SP, signal peptide, TM, trans-
membrane. These elements were identified by hydrophobicity algorithms
(e.g., Phobius), and the absence of a predicted SP or TM does not nec-
essarily mean that a protein is not cell surface/secreted. %, penetrance
of mistargeting phenotypes in larvae overexpressing the gene from
24B-GAL4.976 Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc.phenotypes (12%), but they were seen with a similar frequency
in balancer controls.
Double mutants (trns064117 caps65.2) also had no CNS pheno-
types, and < 7% of hemisegments had a missing muscle. The
penetrances of the ISNb and SNa phenotypes (55% and 60%,
respectively) in double-mutant embryos were roughly doubled
relative to trns064117 single mutants and were higher than those
observed in trn null mutants (Figure 3H). The differences in pen-
etrance between trn and trn caps are statistically significant
(p< .001, chi-square test). This shows that the twogenes interact.
The trn caps phenotype was rescued to20% penetrance for
both ISNb and SNa phenotypes (Figure 3H) by neuronal expres-
sion of Trn driven by Elav-GAL4. Rescue is statistically significant
(see Figure 3 legend), and the ISNb phenotypic penetrance in
neuronal rescue embryos is only slightly higher than in caps sin-
gle mutants, suggesting that loss of Trn from neurons accounts
for the ISNb axon guidance errors. For SNa, the penetrance in
rescued embryos is still considerably higher than for caps single
mutants, so loss of Trn from muscles may also contribute to this
phenotype. We did not examine rescue by GAL4-driven expres-
sion of Trn in muscles, since this produces the dominant pheno-
types that allowed us to identify trn as a gene of interest in our
screen.
Double-mutant ISNbs that passed the center of muscle 13
sometimes exhibited a striking ‘‘terminal loop’’ phenotype at
early stage 17 that has not been described for any other mutant.
It was never observed in trn or caps singlemutants (n = 197 hemi-
segments for trn, n = 202 for caps). Most ISNb nerves with the
loop phenotype had formed synapses at the muscle 6/7 cleft,
showing that overall ISNb development is relatively normal. We
also confirmed that the loop hemisegments all had normal
muscle patterning. The distal edge of the terminal loop was at
themuscle 12/13 junction or on the surface of muscle 13 (Figures
3A–3G).
The terminal loop phenotype is reminiscent of the 12/13
loopback phenotypes observed in the larval screen (Figures 2B
and 2C) and suggests that the RP5 axon destined for muscle
12 did not recognize it as the preferred target and turned back
onto muscle 13. We estimate that >20% of ISNbs in double
mutants that reach the center of muscle 13 have these terminal
loops. However, the exact penetrance of the loop phenotype is
difficult to determine, because the loop appears to involve only
one axon and is thus hard to visualize using immunohistochem-
istry. Also, the phenotype would only be detectable if the loop is
big enough to distinguish. An axon that doubled back on itself
might represent the same phenotype, but we would not be
able to see this unless it was connected to a loop (e.g., Fig-
ure 3B). Note also that we cannot unequivocally determine if
the loops are axons or if they are parts of growth cones, although
growth cones are smaller and are not normally seen at this stage
of development. A structure with a similar appearancemight also
be produced by two axons that separate and then rejoin.
Trn Overexpression on Muscle 12 Alters Targeting
The results described above suggest that loss of both Trn and
Caps can cause the RP5 axon to fail to recognize muscle 12,
so that it turns back onto muscle 13 and forms a loop. Caps is
normally expressed on muscle 12 and has been proposed to
Neuron
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Mutants
(A–C) ISNbs in early stage 17 embryos stainedwith
mAb 1D4 using HRP immunohistochemistry;
these are brightfield images, as the loops are too
faint to see with DIC optics. (A) is a control hemi-
segment. Loops indicated by arrows in (B)–(D);
note that all are at the 12/13 border or on m13.
The 12/13 border is indicated by a line in each
panel. NMJs at the 6/7 cleft indicated by aster-
isks (*).
(E–G) Loops visualized by confocal microscopy.
1D4 is green, Alexa-phalloidin is magenta. (E) is
a control hemisegment, and (F) and (G) are trn
caps. The control hemisegment was stretched
more during dissection so the muscles are wider.
The hemisegment in (F) is an A7, so the ventral
muscles have a different morphology from (E)
and (G). Arrow in (E), muscle 12 NMJ. Arrows in
(F) and (G), terminal loops. Stars (*), muscle 6/7
NMJs. ISNd is indicated in (E) and (F).
(H) Bar graph of total phenotypic penetrances
(% defects) for ISNb and SNa in control (TM3-
GFP/+; n = 468 hemisegments for ISNb, n = 432
for SNa), caps65.2 (n = 202 for ISNb, n = 152
for SNa), trns064117 (labeled as trn-hyp; n = 197
for ISNb, n = 143 for SNa), trn28.4 (labeled as trn
null; n = 216 for ISNb, n = 160 for SNa), trns064117
caps65.2 (labeled as trn-hyp caps; n = 196
for ISNb, n = 140 for SNa), and Elav-GAL4,
UAS-Trn, trns064117 caps65.2 (rescue of trn-hyp
caps by neuronal Trn; labeled as ‘‘Rescue’’;
n = 202 for ISNb, n = 170 for SNa). p < 0.001
(chi-square test) for differences between trn-hyp
and trn-hyp caps, and between trn-hyp caps and
Rescue.
Bar in (A), 10 mm for (A)–(D), 5 mm for (E)–(G).be an attractive cue for RP5, based on the fact that when Caps is
overexpressed on all muscles, the third-instar muscle 12 NMJ
often sends loopback collaterals onto muscle 13 (Shishido
et al., 1998; Figure 2C).
To evaluate Trn’s function in targeting and compare it to that of
Caps, we first defined the expression patterns of Trn protein and
a trn enhancer trap. trn mRNA is expressed in the ectoderm,
mesoderm, tracheae, CNS, and PNS at various stages, and its
expression pattern changes rapidly throughout development
(Chang et al., 1993; Krause et al., 2006). Examination of a trn-
nuclear lacZ enhancer trap shows that trn is transcribed in all
of the VLMs at stages 14 through early 16 (Figure S4).
Trn protein is expressed in a subset of muscle founder cells at
stage 12 (Artero et al., 2003), but its expression in later embryos
has not been described. We stained stage 14–16 embryos with
the rabbit anti-Trn antibody described by Chang et al. (1993).
During late stage 14 through early stage 16, the ventral and
lateral patches of Trn expression are separated by a gap that
corresponds to the region containing muscles 12 and 13(Figure S5), suggesting that Trn protein is expressed at lower
levels on these muscles than on muscles 6 and 7. By late stage
16, Trn protein is no longer detected on the VLMs. In third-instar
larvae, there is no detectable expression of Trn protein in the
VLM region (data not shown).
To evaluate the consequences of Trn muscle overexpression,
we drove the GS10885 (trn EP) line with three different GAL4
drivers and examined third-instar larvae. These are 24B, H94,
and 5053A. H94 drives expression in muscles 13, 6, and 4, and
at low levels in 12; it turns off by the end of embryogenesis
and is weaker than 24B. 5053A is selective for muscle 12 only
and drives high-level expression in both embryos and larvae
(Figure S6).
All three drivers generated mistargeting at high frequencies
(37%–60%; Figure 4H). 24B-GAL4 3 GS10885 (abbreviated as
24B::Trn) and H94::Trn both produced a spectrum of mistarget-
ing defects. The most common 24B::Trn phenotypes (see bar
graph; Figure 4I) were innervation of muscle 12 from the dorsal
side by unknown axons (type 3; Figure 4C) and 12/13Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc. 977
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H94::Trn produced type 1, type 2 (reduced innervation of 12),
and type 8 (no innervation of 13; Figure 4E). These phenotypes
are hard to interpret mechanistically, because ISNb axons tra-
verse multiple Trn-overexpressing muscles during outgrowth,
and the mistargeting axons sometimes cannot be identified.
Bycontrast,whenmuscle 12 innervation is examined incrosses
where the muscle 12-specific 5053A-GAL4 is used to drive
perturbing agents, the results can be more easily interpreted, be-
cause the axons are known and only the last stage of their target-
ing should be affected. In 5053A::Trn larvae, the most prevalent
phenotypes (Figure 4I) were type 2 (reduced innervation of 12;
Figure 4. Trn Overexpression in Muscle
Subsets Causes Mistargeting
(A) Classification of observed mistargeting pheno-
types. Green lines indicate normally patterned
NMJs on muscles 6, 7, 12, and 13. The TN is indi-
cated at the left. Red lines indicate ectopic (mistar-
geted) NMJs.
(B–G) Confocal z-stack images of the VLM regions
of 3rd instar F1 larvae stained with 1D4 (anti-FasII;
green). Muscles (gray) were visualized by UAS-
GFP driven by 24B-GAL4 (B andC) or by phalloidin
staining (D–G). (B) Control (UAS-GFP, 24B-GAL4 x
w). (C) Overexpression of intact Trn (in GS10885 x
UAS-GFP, 24B-GAL4). Arrow in (C), ectopic NMJ
wrapping over the dorsal edge of m12 (type 3).
Arrowheads in (C), ectopic NMJ on m12/13, pre-
sumably split off from the normal NMJ. (D and E)
Trn overexpression on muscles 13 and 6 (in
GS10885 3 H94-GAL4). Arrow in (D), ectopic in-
nervation of m6 (type 7); arrow in (E) indicates
the absence of innervation on m13 (only an axon
traversing m13 is observed; type 8). (F and G)
Trn overexpression on m12 only (in GS10885 3
5053A-GAL4). Arrow in (F), a branch of the m13
NMJ extends dorsally but there is no innervation
of m12 (type 2); arrow in (G), the NMJ on m12
emerges from under m13, and there is no axon
crossing over m13 (type 5).
(H) Bar graph of total phenotypic percentages.
Numbers of A2 hemisegments examined indi-
cated on bars.
(I) Bar graph showing the distribution of pheno-
types among the categories illustrated in (A).
Bar in (B), 50mm: applies also to (C)–(G).
Figure 4F) and type 5 (muscle 12-innervat-
ing axonsgrowunder 13 to reach12 rather
than over it; Figure 4G). The type 2 pheno-
type could be interpreted as repulsion
from muscle 12 when it expresses Trn,
but the type 5 phenotype is not readily ex-
plained in thecontextof a simpleattractive
or repulsivemodel, sinceTrnonmuscle12
seems to be affecting RP5 axonal growth
past the adjacent muscle 13 (a nonauton-
omous effect).
To better understand the effects of
driving targeting cues on muscle 12, we
expressed Caps from 24B, H94, and 5053A. Consistent with
published data (Shishido et al., 1998), the phenotypes observed
in crosses of UAS-Caps to 24B-GAL4 were primarily type 1
(12/13 loopbacks; 70%); this was also observed for H94-
driven expression. If Caps is an attractive cue for muscle 12
innervation by RP5, as suggested by these results, then driving
excess expression on muscle 12 might be expected to have
no effect. However, we found that overexpressing Caps onmus-
cle 12 produced primarily type 2 and type 5 phenotypes, exactly
as observed for Trn (Figure S7). This indicates that Caps cannot
be understood in simple terms as an attractive muscle 12 cue.
Rather, muscle 12 expression of either Caps or Trn produces
978 Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc.
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of increased occupancy of the putative neuronal Caps/Trn re-
ceptor (see below for further discussion). In addition, our embry-
onic data (Figure 3) and published results (Taniguchi et al., 2000)
show that neuronal Caps and Trn are also important for axon
guidance. These neuronal functions might involve interactions
with a different receptor(s).
CG14351/Haf Is a Targeting Cue Required
for Innervation of All Ventrolateral Muscles
We initially characterized CG14351 expression and LOF pheno-
types in embryos. There are two GAL4 enhancer trap lines just
upstream of the 50 end of the sequenced CG14351 Drosophila
gold collection (DGC) cDNA, with insertion sites separated by
130 bp. One has an expression pattern (http://flymap.lab.nig.
ac.jp/dclust/getdb.html) described as ‘‘muscle subset plus
salivary glands,’’ and the other as ‘‘CNS, gut subset, salivary
glands.’’ The ‘‘muscle subset’’ insertion line, P(GawB)NP0212,
drives lacZ expression at highest levels in the VLMs and ventral
muscles during part of stage 16 (Figure S2).
To examine protein expression, we made a mouse antibody
against a fragment of the XC domain expressed in E. coli. We
confirmed that the antibody recognizes the protein by showing
that it stained the appropriate striped pattern in germ-band
extended embryos in which CG14351 was driven by engrailed-
GAL4 (data not shown). In wild-type embryos, the antibody
stains muscles, the CNS, the PNS, and the salivary glands (Fig-
ure S2). Thus, motor axon phenotypes caused by CG14351 LOF
mutations could arise from loss of expression in neurons,
muscles, or both.
We were primarily interested in whether CG14351 functions
as a muscle targeting cue, so we examined both conventional
mutations and CG14351 RNAi constructs expressed in muscles.
The RNAi lines were generated by the Vienna Drosophila RNAi
Center (VDRC) (Dietzl et al., 2007) and the National Institute of
Genetics, Japan (NIG). As described below, three insertion
mutations and two independent RNAi constructs crossed to
panmuscle drivers all produced strong ISNb phenotypes and
generated similar kinds of targeting errors.
The CG14351 gene spans 53 kb and has a 43 kb second intron
that contains coding exons for two other genes of unknown
function. The CG14351 coding sequence is all 30 to this intron.
We examined two PiggyBac splice-trap insertions from the
Exelixis collection within the second intron, RBe04649 and
RBe02960. These are unidirectional splice traps and are >7 kb
away from the transcribed regions for the two embedded genes
(CG10869, CG31935), both of which are transcribed in the oppo-
site direction from CG14351. (See http://flybase.bio.indiana.
edu/cgi-bin/gbrowse/dmel/?Search=1;name=FBgn0031349 for
the transcript map.)
We also obtained a line, LL01240, with an insertion of a new
splice-trap PiggyBac vector (Schuldiner et al., 2008) at position
903 relative to the 50 end of the DGC cDNA. Based on the
LL01240 phenotype (see below), we speculate that there may
be additional 50 untranslated exon(s) in this gene, so that
LL01240 would perturb splicing. The LL01240 insertion should
only affect the CG14351 gene, as it is >30 kb from any other
gene. To confirm that the LL01240 phenotype is not due to otherinsertions on the chromosome, we examined it in transheterozy-
gous combinations with two different deficiency (Df) mutations
that remove the CG14351 gene, as well as in transheterozygotes
with RBe02960.
We obtained three UAS-driven RNAi lines for CG14351 from
the VDRC and NIG collections. The sequences used for the
UAS-RNAi constructs differ between VDRC and NIG lines. All
three produced lethality when crossed to a strong pancellular
driver, tubulin (tub)-GAL4. These pancellular RNAi embryos
also had CNS defects. Knockdown of neuronal CG14351 by
crossing Elav-GAL4 to the strongest RNAi line, VDRC2, also
produced alterations in the CNS axon ladder, suggesting that
neuronal CG14351 is involved in axon guidance (data not
shown). However, the insertion mutations did not produce
CNS defects.
All three insertion mutants and the two strongest RNAi lines
crossed to muscle drivers produced a similar spectrum of
embryonic ISNb phenotypes, as assayed by staining with mAb
1D4. These are ordered by phenotypic strength as follows:
VDRC2 3 24B-GAL4 (60% of hemisegments have defects) >
LL01240 (homozygotes or over Dfs; 50%) > RBe04649,
RBe02960, NIG2 3 24B-GAL4, and VDRC2 3 G14-GAL4
(30%–40%). Driver-alone and balancer/+ controls were all
<10% (Figure 5K).
A wide variety of phenotypes were seen, including the follow-
ing: (1) bypass phenotypes in which the ISNb failed to enter the
VLM field and instead followed the ISN or SNa pathway (Figures
5B and 5C); (2) stall phenotypes in which the ISNb ended ventral
to muscle 13, often following a incorrect trajectory to the stall
point (Figures 5D–5F); (3) ISNbs with several different kinds of
abnormal trajectories (classified as ‘‘other’’; phenotypic distribu-
tion in Figure 5L). Among these were: growth onto the TN (Fig-
ures 5F and 5G), growth past the VLMs to contact lateral muscle
5 (Figure 5I), growth to the dorsal edge of the VLMs followed by
splitting (Figure 5J), and splitting at or near the exit junction (Fig-
ures 5E and 5H).
In summary, our data indicate that CG14351 is required for
normal motor axon targeting into and within the VLM field. No
consistent guidance errors are produced by loss of muscle
CG14351. Rather, ISNbs appear to make a variety of different
abnormal decisions, suggesting that they are unable to choose
a trajectory. The phenotypes are specific for VLM and ventral
muscle fields, as few errors (<10% penetrance) were observed
for SNa (lateral muscles) and the ISN (lateral and dorsal muscles).
To further analyze CG14351 function, we drove the VDRC3
and NIG2 RNAi constructs with 24B, H94 (13,6,4), and 5053A
(12 only) and examined the consequences in third-instar larvae
(larvae do not survive when the strongest construct, VDRC2, is
crossed to 24B-GAL4). All three drivers produced mistargeting
phenotypes, with 24B-driven VDRC3 RNAi generating the high-
est penetrance (>40% of A2 hemisegments; Figure 6J). A variety
of different phenotypes were seen with 24B and H94, including
type 1 (12/13 loopback; Figure 6D), type 7 (innervation of m6
from the dorsal side; Figure 6E), type 2 (reduced innervation of
12; Figure 6I), and type 3 (innervation of 12 from the dorsal
side; Figure 6I). CG14531 overexpression (EY112443 24B) pro-
duced a different spectrum of phenotypes, with type 1 (12/13
loopback; Figure 6B) and type 7 (innervation of 6/7 from theNeuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc. 979
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Phenotypes in Embryos
(A–J) ISNb nerves (brown) in late stage 16/early
stage 17 embryos stained with mAb 1D4, visual-
ized with HRP immunohistochemistry and DIC op-
tics. m12 is labeled for reference in many panels;
arrows indicate m6/7 NMJs, triangles indicate
LBD cells (part of the TN), and double arrowheads
indicate the SNa. Single arrowheads in (A)–(C):
ISN. The allele in all images of mutants is
LL01240. (A) Early stage 17 control. (B and C) By-
pass phenotypes, in the haf mutant. In the left
hemisegment in (B) the ISNb extends along the
SNa, while in the right hemisegment in (B) and
the left hemisegment in (C), it extends along the
ISN. In the right hemisegment in (C), the ISNb ap-
pears to initially follow the SNa, then leave it and
extend onto the VLMs. (D–F) Various kinds of stall
phenotypes. (D and E) VDRC2 haf RNAi 3 24B-
GAL4. The ISNb is truncated and curled, ending
at the 6/7 cleft in (D); in (E) the ISNb is split at the
exit junction; one part stops at the 6/7 cleft, and
the other forms an abnormal branch to m14 (aster-
isk). (F) VDRC2 haf RNAi x G14-GAL4. The ISNb
stops at the 6/7 cleft and forms a forked NMJ.
(G–J) ‘‘Other’’ phenotypes. (G) VDRC2 haf RNAi
3 24B-GAL4. The ISNb emerges into focus, grows
across the internal surfaces of the VLMs, and joins
the TN at the point marked by the arrowhead. (H)
VDRC2 haf RNAi x G14-GAL4. The ISNb splits,
forming a short ventral branch (*); the remainder
of the nerve grows over the VLMs, forming NMJs
at m6/7 and m12/13, then joins the TN (arrow-
head), which has abnormally crossed over the
ISN. (I and J) haf mutant. In (I) the ISNb grows un-
derneath the VLMs, splits at the dorsal edge of
m12, and sends one branch to the LBD, while
the other branch (arrowhead) contacts the lateral
muscle m5. In (J), the ISNb grows on top of the
VLMs and splits (arrowhead) at the dorsal edge
of m12. One branch extends along the muscle
edge, while the other follows the ISN pathway.
(K) Bar graph of phenotypic penetrances for the
mutant and RNAi lines. n = 135 hemisegments
for the RBe04649 mutant, n = 203 for RBe02960,
n = 418 for LL01240, n = 226 for VDRC2 RNAi 3
24B-GAL4, n = 243 for VDRC2 RNAi 3 G14-
GAL4, n = 193 for NIG RNAi 3 24B-GAL4, n =
231 for 24B-GAL4 3 w control, n = 129 for G14-
GAL4 xw control. Penetrances of other genotypes
not indicated on bar graph: LL01240/Df(2L)dp-79b, 51% (n = 218), LL01240/Df(2L)ast2, 57% (n = 267), LL01240/RBe02960, 32% (n = 264). Differences between
mutants/RNAi and controls are significant (p < 0.001, chi-square test).
(L) Distribution of phenotypes in selected haf mutant and RNAi genotypes.
Bar in (A), 20 mm; applies to all panels.dorsal side; Figure 6C) being most common. Since CG14351 is
normally expressed on the VLMs, these phenotypes are either
due to excess signaling through muscle CG14351 or to an alter-
ation in the relative amounts of CG14351 on the VLMs versus
other muscle groups.
Driving CG14351 RNAi with 5053A-GAL4 produced a unique
phenotype (>40% of affected hemisegments) in which the
muscle 12 innervating axons sent ectopic branches to lateral
muscles 5 or 8 (Figures 6G and 6H). This phenotype was also
seen in the embryo (Figure 5I).980 Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc.Based on these findings, and on the fact that the other twomu-
tations in this phenotypic category (inability to find VLM targets,
with generation of varied ISNb phenotypes) are named clueless
(an allele of ab) and walkabout (wako) (Hu et al., 1995; Vactor
et al., 1993), we named this gene hattifattener (haf), an English
translation of a word invented for theMoomin stories by the Finn-
ish author Tove Jansson. Hattifatteners are worm-like creatures
that float randomly around the world in little boats. In Japan,
they are called Nyoro-nyoro (see http://en.wikipedia.org/wiki/
Hattifattener).
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Mistargeting Phenotypes
24B-GAL4-driven expression of CG8561 from two different
EP-like lines (GS10548 andGE12785) produced synaptic bouton
phenotypes andmistargeting (Figures 7B, 7H, and 7J; Table S4).
We could not detect CG8561 mRNA in embryos using in situ
hybridization. To examine protein expression, we generated a
mouse antiserum against a fusion protein made in E. coli and
a rabbit antiserum against a synthetic peptide. Both antisera
were verified as being able to recognize ectopically expressed
CG8561 as described above for anti-Haf. Staining with either
Figure 6. Expressing haf (CG14351) RNAi in
Muscle Subsets Causes Mistargeting
(A–I) Confocal z-stack images of 3rd instar F1 lar-
vae stained with 1D4 (green) and Alexa-phalloidin
or UAS-GFP expression (gray). (A) Control (UAS-
GFP, 24B-GAL4 x w). (B and C) Haf muscle over-
expression (in EY11244 3 UAS-GFP, 24B-
GAL4). Arrow in (B), loopback collateral from
m12 onto m13 (type 1). Arrow in (C), ectopic inner-
vation of m6 (type 7). (D and E) VDRC3 haf RNAi3
UAS-GFP, 24B- GAL4. Arrow in (D), 12/13 loop-
back (type 1). Arrow in (E), ectopic m6 innervation
(type 7). (F) NIG2 haf RNAi 3 UAS-GFP, 24B-
GAL4. Arrow, a long loopback collateral from
m12 to m6. (G and H) VDRC3 haf RNAi x 5053A-
GAL4 (muscle 12 only). Arrows, axons not only
make normal NMJs on m12 but also arborize on
m5 (arrow in [G]) or m8 (arrows in [H]). (I) VDRC3
haf RNAi x H94-GAL4 (muscles 13, 6). Arrows, ec-
topic NMJ wrapping over the dorsal edge of m12
(type 3); arrowhead, abnormal ending on m13 (ex-
treme type 2). Asterisk, normal NMJ on m30/14.
(J) Bar graph of mistargeting penetrances in
control, overexpression, and RNAi larvae with
panmuscle or muscle subset drivers. Number of
A2 hemisegments examined indicated on bars.
(K) Bar graph showing the distribution of mistar-
geting phenotypes among the categories illus-
trated in Figure 4A.
Bar in (A), 50mm; applies also to (B)–(I).
antiserum showed that in wild-type em-
bryos CG8561 is expressed in muscles,
tracheae, and CNS axons. It is also local-
ized to the NMJ in third-instar larvae
(Figure S3).
There are no insertion mutations in the
CG8561 gene. We obtained an RNAi line
for CG8561 from the VDRC and crossed
this to a variety of drivers. When crossed
to tub-GAL4, CG8561 RNAi produced
embryonic/early larval lethality, and the
embryos had an uncondensed ventral
nerve cord (Figure S8). No phenotypes
were produced by crossing CG8561
RNAi to the pan-neuronal driver Elav-
GAL4.
CG8561 RNAi 3 24B-GAL4 embryos
did not have motor axon phenotypes.
However, third-instar larvae expressing CG8561 RNAi in mus-
cles displayed mistargeting and synaptic bouton phenotypes,
and these were stronger than the overexpression phenotypes
we initially identified in the screen (Figures 7B and 7H). Thirty-
eight percent of A2 muscle RNAi hemisegments had mistarget-
ing phenotypes, 80% of which were type 1 (12/13 loopback;
Figure 7C), while 69% had bouton phenotypes, characterized
by tangled arbors that failed to extend normally along the 6/7
cleft (Figure 7I).
As with Haf, we also drove CG8561 RNAi in muscle subsets
with H94 and 5053A. We obtained a clear result with 5053ANeuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc. 981
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Figure 7K) had 12/13 loopback phenotypes (type 1; Figure 7F).
DISCUSSION
We assembled a database of 976 Drosophila CSS proteins that
are likely to be involved in cell recognition events during develop-
ment (TableS1).We foundEP lines that allowedus toexpress 410
of these genes in muscles (Table S2) and defined all the genes
that alter presynaptic NMJ terminal patterning and structure
without visibly affecting themuscles themselves (screen summa-
rized in Figure 1A). The screen identified 30 genes that cause
mistargeting of axons within the VLM field with a penetrance of
R30% (Tables 1 and S3; Figure 2), and 55 genes that produce
Figure 7. Expressing CG8561 RNAi in Mus-
cles Causes Mistargeting and Synaptic
Phenotypes
(A–C) Confocal z-stack images of 3rd instar F1 lar-
vae stained with 1D4 (green) and Alexa-phalloidin
or UAS-GFP expression (gray). (A) Control (UAS-
GFP, 24B-GAL4 x w). (B) CG8561 muscle overex-
pression (in GS10548 3 UAS-GFP, 24B-GAL4).
Arrow, long loopback collateral from m12 to m6
(type 1). (C) CG8561 RNAi 3 24B-GAL4. Arrow,
m12/m13 loopback (type 1). Arrowhead, tangled
NMJ arbor.
(D) CG8561 RNAi x H94-GAL4 (muscles 13, 6). Ar-
row, abnormal NMJ on m12 emerging from under
m13 (type 5). Asterisk, normal NMJ on m30/14.
(E and F) CG8561 RNAi 3 5053A-GAL4 (muscle
12 only). Arrow in (E), ectopic innervation of m6
(type 7); arrow in (F), m12/m13 loopback (type 1).
(G–I) Confocal z-stacks showing higher-magnifi-
cation views of the 6/7 NMJ in the indicated geno-
types. In (H), boutons are fused. In (H) and (I), the
arbor is tangled.
(J) Bar graph of penetrances for mistargeting and
synaptic bouton phenotypes in control, overex-
pression, and RNAi larvae. Numbers of A2 hemi-
segments examined indicated on bars.
(K) Bar graph showing the distribution of mistar-
geting phenotypes among the categories illus-
trated in Figure 4A.
Bar in (A), 50mm; applies also to (B)–(F); in (G),
20mm; applies also to (H)–(I).
major alterations in synaptic boutons
or the structures of NMJ arbors with
R60% penetrance (Figure S1; Table S4).
LRR genes represented 5 of the 12mis-
targeting genes of interest (groups 1 and 3
in Table 1). To evaluate the roles of the
LRR genes in synaptic targeting, we ex-
amined LOF mutants, and also knocked
down or overexpressed the genes using
both panmuscle drivers and drivers ex-
pressed only in specific muscle fibers.
For mechanistic analysis, we focus here
primarily on results obtained by driving
targeting genes or RNAi constructs in
muscle 12 only (driver pattern in Figure S6) and examining the
consequences for innervation of muscle 12 by RP5 and the 1s
neuron. These results are interpretable because the axons are
known and only the last stage of their targeting should be af-
fected.By contrast,mistargeting phenotypes observedwith pan-
muscle expression could result from errors at any point along the
axonal trajectory, and the axons thatmistargeted cannot be iden-
tified in many cases. There may also be targeting errors that we
cannot detect using mAb 1D4, because it labels all motor axons.
We can only see NMJs that display morphological abnormalities
and thus couldmiss phenotypes inwhich an axon fromonemotor
neuron is replaced by another one, if it forms a similar NMJ. Ide-
ally, these experiments should be performed using reagents that
label single identifiedmotor axons, but thesearenot yet available.982 Neuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc.
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Overexpression and Knockdown of LRR
Genes
Representative phenotypes caused by m12-
specific perturbations (genes or RNAi driven by
5053A-GAL4) are illustrated. Dotted lines indicate
that axons travel under (external to) m13, m6, and
m7. OE, overexpression.Tartan and Capricious Have Redundant
Functions in Targeting
LRRs are 24 aa protein domains that can be found outside the
cell or in cytoplasmic proteins. A chain of LRRs forms a concave
binding surface that is used for interactions with other proteins.
The LRRdomains of Trn andCaps are interchangeable, suggest-
ing that they can interact with a common receptor (Milan et al.,
2005). Trn and Caps are involved in cell-cell interactions in
tracheae and imaginal discs, and Caps regulates layer-specific
targeting in the optic lobe (Krause et al., 2006; Milan et al.,
2001; Shinza-Kameda et al., 2006).
Within the VLM field, Caps is expressed on muscle 12 (Shish-
ido et al., 1998), while Trn appears to be expressed on all VLMs,
but with higher levels onmuscles 6 and 7 (Figures S4 and S5). trn
caps double mutant embryos have stronger motor axon pheno-
types than trn singlemutants, and they exhibit ISNb terminal loop
phenotypes that are suggestive of RP5 mistargeting (Figure 3).
Becausemuscle 12 NMJs send loopback branches ontomus-
cle 13 when Caps is expressed in all muscles, it was proposed to
be an attractive cue which facilitates targeting of RP5 to muscle
12 (Shishido et al., 1998). However, the actual situation may be
more complex, because selective overexpression of either
Caps or Trn onmuscle 12 produces phenotypes in whichmuscle
12-destined axons either stall on muscle 13 (type 2), so that
muscle 12 remains uninnervated, or grow undermuscle 13 rather
than over it to reach muscle 12 (type 5; Figures 4, 8, and S7).
These apparently nonautonomous effects (alteration of axonal
extension over an adjacent muscle) might be explained by Trn-
or Caps-induced alterations in the pattern of myopodia, projec-
tions from themuscle that reach out to contact innervating axons
and direct their growth. Myopodia can extend over distances
similar to the width of a muscle fiber (Ritzenthaler and Chiba,
2003; Ritzenthaler et al., 2000). Perhaps when Trn or Caps is
expressed on muscle 12, the myopodia extend under muscle
13 rather than over it. If RP5 axons contact these aberrant myo-
podia, they may grow under 13 to reach 12; if they fail to contact
them, they may stall on muscle 13.
Haf/CG14351 Is Necessary for Axonal Targeting
to All Ventrolateral Muscles
CG14351, which we denoted as Haf, is a large protein (1316 aa),
and LRRs occupy only aa 100–350 of the XC domain. Haf has
a signal sequence, a single transmembrane region, and a large
cytoplasmic domain (500 aa). It appears to be expressed by
all VLMs (Figure S2).
The embryonic motor axon phenotypes observed in the haf
insertion mutant and in haf RNAi x pan-muscle-GAL4 embryos
indicate that ISNb cannot innervate any of the VLMs in a normal
manner if Haf is not expressed in muscles. Only 40%–50% ofISNbs have a normal morphology. The remainder bypass onto
the ISN or SNa or follow abnormal trajectories within the VLM
field, sometimes contacting inappropriate targets (Figure 5).
The phenotypes are highly variable, suggesting that many
different kinds of errors are produced by loss of Haf.
We suggest that in the embryo Haf is a permissive muscle
factor that is required for target selection by all muscles within
the VLM field but does not define the identities of specific fibers.
This model is also consistent with the larval phenotypes that
result from knocking down Haf expression on muscle 12 only.
In this case, the RP5 and 1 s axons seem to reach muscle 12
and form NMJs in a normal manner, but they also extend further
and form ectopic synapses on lateral muscles 5 or 8 (Figures 6
and 8). This phenotype suggests that a stable NMJ on muscle
12 sometimes cannot form when Haf is knocked down, and in
these cases the axons (or NMJ branches) continue to grow until
they reach the lateral muscles.
CG8561 Mediates Synaptic Targeting and Arbor Growth
CG8561 is a 1092 aa protein that has a signal sequence but lacks
a transmembrane region. Its C-terminal sequence is characteris-
tic of proteins that are attached tomembranes by glycosyl-phos-
phatidylinositol anchors. It appears to be expressed by all
muscles (Figure S3).
CG8561 muscle RNAi and muscle overexpression produce
mistargeting and NMJ arbor phenotypes in larvae. When
CG8561 RNAi is expressed in muscle 12 only, the muscle 12
NMJ sends loopback branches to muscle 13 in 70% of affected
hemisegments (Figures 7 and 8). This implies that CG8561 con-
fers a preference for the RP5 and 1 s axons to choosemuscle 12,
and in its absence these axons do not strongly prefer muscle 12
to the adjacent muscle 13.
CG8561 has a vertebrate ortholog, the acid-labile subunit (Als)
of the IGF-1 binding complex. CG8561mRNA is expressed in the
larval fat body (FB) and in a group of neurosecretory cells (NSCs)
that express insulin-like peptides. Starvation causes downregu-
lation of the mRNA in the FB and NSCs. These data suggest that
CG8561 (dAls) may be involved in insulin/IGF-1 signaling (Co-
lombani et al., 2003). Interestingly, the single fly insulin/IGF-1 re-
ceptor, InR, is expressed in neurons and is required for guidance
of photoreceptor axons into the optic lobe (Song et al., 2003).
The Future of Target Selection
in the Neuromuscular System
Our identification of 30 mistargeting genes among the 410 CSS
genes we screened suggests that there may be 70 mistarget-
ing genes in the entire cell-recognition database, and perhaps
twice that many if genes with lower mistargeting percentages
are included. If we assume that the screen is capable ofNeuron 59, 972–985, September 25, 2008 ª2008 Elsevier Inc. 983
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seem inconsistent with a simple version of the lock-and-key
model discussed in the Introduction, because we did not find
mRNAs or proteins within the mistargeting set that are ex-
pressed in small subsets of muscles. Also, the four LRR proteins
examined in this paper have complex effects on targeting that
are not explainable by a simple model (Figure 8).
We screened 53 LRR proteins, and 16 of these produced
mistargeting, NMJ phenotypes, or both (Table S4). If the failure
of an LRR protein to produce a phenotype when overexpressed
in muscles in the course of our screen indicates that it is not
involved in targeting or synapse development, then there are
48 signal sequence-containing LRR proteins that remain to be
examined for expression patterns, GOF phenotypes, and LOF
phenotypes. A comprehensive analysis of this large family may
help to define mechanisms involved in target selection and
synaptic growth.
EXPERIMENTAL PROCEDURES
Analysis of Larval and Embryonic Phenotypes
For third-instar larval preparations, dissected fillets were fixed for 30 min with
4% paraformaldehyde at room temperature. Washing was done with 0.3%
Triton X-100 in PBS. Blocking was done with 0.3% Triton X-100 + 0.1%
BSA + 5% normal goat serum in PBS. Incubation with primary antibody was
done overnight at 4C. Labeled fillets weremounted with anti-fade Vectashield
medium (Vector Laboratories, Inc., Burlingame, CA USA). Confocal images
were captured with an LSM510 instrument. Images were processed using
Adobe Photoshop. Staining of whole-mount embryos was done as described
by Patel (1994). Staining of live-dissected embryos was done as in Fox and
Zinn (2005). The following primary antibodies were used: mouse anti-FasII
mAb 1D4 (DSHB), diluted 1:5; mouse anti-Futsch mAb 22C10 (DSHB) diluted
1:4; rabbit anti-Trn (Chang et al., 1993), diluted 1:400; mouse anti-Haf diluted
1:200; rabbit anti-CG8561 diluted 1:1000; mouse anti-CG8561 diluted 1:200;
rat anti-Troponin T1 diluted 1:500 (Abcam Inc., Cambridge, MA, USA); goat
anti-horseradish peroxidase (HRP) (Jackson ImmunoResearch, West Grove,
PA, USA). Alexa Fluor-conjugated phalloidin was diluted 1:40 (Invitrogen-
Molecular Probes, Carlsbad, CA, USA). Cy3-conjugated or HRP-conjugated
secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA)
were used at dilutions of 1: 400 (Cy3) or 1:200 (HRP).
Antibodies against Haf were generated using a GST fusion protein contain-
ing aa 543-689. Antibodies against CG8561 were made using a GST fusion
protein containing aa 683-1019, or against a synthetic peptide (aa 1030–
1046; VSRDSDGNTRKWFSGQC). Protein was purified from inclusion bodies
in E. coli and injected into mice at the Caltech Monoclonal Antibody Facility,
or into rabbits at a commercial facility (Medial & Biological Laboratories Co.,
Ltd).
SUPPLEMENTAL DATA
The Supplemental Data include eight figures, four tables, and Supplemental
Text and can be found with this article online at http://www.neuron.org/cgi/
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